# Bridge Investment Fund

> Bridge Investment Fund is a VC fund backing Health Care and Biotechnology. See 2 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Cleveland, United States
- Total investments: 2
- Last investment: Jul 2010
- Lead investor: 50%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/bridge-investment-fund/
- Website: http://www.bridgefundllc.com

Bridge Investment Fund is a venture capital fund focused on investing in Israeli medical device companies with strong synergies with the leading health care institutions and industries in Cleveland. With offices in Cleveland and Tel Aviv, Bridge is specifically focused on Israeli medical device companies that have completed their initial clinicaltrials and are looking to the US market for further clinical validation and to establish a US sales marketing organization.

## Contacts

5 contacts available for Bridge Investment Fund. Shizune tracks 2 team members at Bridge Investment Fund. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/bridge-investment-fund?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 100% |
| Biotechnology | 2 | 100% |
| Medical Device | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series C | 1 | 50% |
| Funding Round | 1 | 50% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Avshalom Horan | Manager | 0 | https://shizune.co/investors/profile/avshalom-horan |
| Michael Goldberg | Manager | 0 | https://shizune.co/investors/profile/michael-goldberg-3 |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| EarlySense | EarlySense develops signal-processing technology. The company's lead product, EverOn, a contact-free early detection patient supervision system that measures, records, displays, and alerts heart and respiration rates, as well as bed entries and exits, patient motion, and quality of sleep from under the mattress. EarlySense Ltd. was founded in2004 and is based in Ramat Gan, Israel with a research and development facility in Israel; and marketing offices in Boston, Massachusetts. | $13M | Series C | Jul 23, 2010 |  |
| CritiSense | CritiSense was founded in 2004 on the basis of the assets of an earlier company named Vital Medical. The company's device, the Critiview, was developed by the company's co-founder and chief scientist, Professor Avraham Mayevsky, formerly head of the department of Department of Life Sciences and Dean of the Faculty of Natural Sciences atBar Ilan University, where he established a center for tissue physiology. It provides continuous, real-time multi-parametric physiological data at the tissue and cellular level, by monitoring the mitochondrial function and the microcirculatory blood flow and oxygen saturation, by way of tissue titration therapy with an optical sensor. | $1.2M |  | Jun 21, 2006 |  |

2 of 2 investments shown.

## Co-investors
- [Docor International Management](https://shizune.co/investors/profile/docor-international-management) — VC Fund, 2 deals together
- [Noaber](https://shizune.co/investors/profile/noaber) — VC Fund, 1 deal together
- [Pitango VC](https://shizune.co/investors/profile/pitango-venture-capital) — VC Fund, 1 deal together
- [Pontifax](https://shizune.co/investors/profile/pontifax) — VC Fund, 1 deal together
- [ProSeed Venture Capital Fund](https://shizune.co/investors/profile/proseed-venture-capital-fund) — VC Fund, 1 deal together
- [The Challenge Fund](https://shizune.co/investors/profile/the-challenge-funds) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Sequoia Capital](https://shizune.co/investors/profile/sequoia-capital) — VC Fund
- [New Enterprise Associates](https://shizune.co/investors/profile/new-enterprise-associates) — VC Fund
- [Bessemer Venture Partners](https://shizune.co/investors/profile/bessemer-venture-partners) — VC Fund

## FAQ

### What does Bridge Investment Fund invest in?

Bridge Investment Fund invests primarily in Health Care, Biotechnology and Medical Device startups, most often at Series C and Funding Round stage. Most of the 2 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Bridge Investment Fund?

Public channels for Bridge Investment Fund include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Bridge Investment Fund?

The team at Bridge Investment Fund includes Avshalom Horan (Manager) and Michael Goldberg (Manager). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co